2 studies on P53 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This detailed structural characterization provides a fundamental understanding of how FOXO4-DRI exerts its senolytic effects, by directly targeting and modulating the p53 pathway through a unique transient binding mec…
This research highlights FOXO4-DRI as a potent anti-senolytic agent, capable of rejuvenating endothelial cells and improving vascular health by modulating the P53 pathway. The ability to reverse cellular aging in the …